News & Updates

Findings from the DOTS trial presented at ESCMID Global 2024 underpin the potential of dalbavancin, a long-acting lipoglycopeptide, for the management of complicated Staphylococcus (S.) aureus bacteraemia (SAB) without requiring long-term vascular access.

In people with rheumatic and musculoskeletal diseases (RMDs), inactivated COVID-19 vaccines prove safe and effective at lowering the risk of COVID-19–related pneumonia, as shown in a study from China.

For people who have successfully undergone Helicobacter pylori-eradication therapy, the use of aspirin does more good than harm, such that the benefit of reduced gastrointestinal (GI) cancer-related mortality outweighs the risk of bleeding-related mortality, according to a study.

The portable micro-PCR accurately determines HIV-1 and HIV-2 viral loads at the same time and can be deployed in remote places where HIV quantification is not feasible, reports a study. This novel device measures HIV viral loads using a TruePrep extractor device for isolating RNA.

Fluctuations in HbA1c levels in between clinic visits may put individuals with type 2 diabetes (T2D) at increased risk of serious infections, according to a study.

Sequential treatment with the oral antibiotic fosfomycin appears to be safe and effective in the management of patients with acute bacterial prostatitis secondary to multidrug-resistant Escherichia coli, according to the phase IV FOS-PROST study.